NeuroOne Medical Technologies Corporation (NMTC)
NMTC Stock Price Chart
Explore NeuroOne Medical Technologies Corporation interactive price chart. Choose custom timeframes to analyze NMTC price movements and trends.
NMTC Company Profile
Discover essential business fundamentals and corporate details for NeuroOne Medical Technologies Corporation (NMTC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
15 Mar 2018
Employees
17.00
Website
https://n1mtc.comCEO
David A. Rosa
Description
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
NMTC Financial Timeline
Browse a chronological timeline of NeuroOne Medical Technologies Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.58, while revenue estimate is $2.55m.
Earnings released on 12 May 2026
EPS came in at -$0.25 falling short of the estimated -$0.23 by -10.29%, while revenue for the quarter reached $2.39m , missing expectations by -7.24%.
Stock split effective on 16 Apr 2026
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 Feb 2026
EPS came in at -$0.18 surpassing the estimated -$0.24 by +25.00%, while revenue for the quarter reached $2.89m , beating expectations by +8.93%.
Earnings released on 17 Dec 2025
EPS came in at -$0.05 falling short of the estimated -$0.04 by -25.00%, while revenue for the quarter reached $2.72m , beating expectations by +9.92%.
Earnings released on 14 Aug 2025
EPS came in at -$0.03 surpassing the estimated -$0.05 by +40.00%, while revenue for the quarter reached $1.70m , missing expectations by -6.64%.
Earnings released on 13 May 2025
EPS came in at -$0.07 surpassing the estimated -$0.09 by +22.22%, while revenue for the quarter reached $1.39m , beating expectations by +9.43%.
Earnings released on 12 Feb 2025
EPS came in at $0.06 surpassing the estimated -$0.10 by +160.00%, while revenue for the quarter reached $6.30m , beating expectations by +200.00%.
Earnings released on 17 Dec 2024
EPS came in at -$0.11 falling short of the estimated -$0.09 by -22.22%, while revenue for the quarter reached $272.28k , missing expectations by -84.87%.
Earnings released on 14 Aug 2024
EPS came in at -$0.10 falling short of the estimated -$0.09 by -11.11%, while revenue for the quarter reached $825.78k , missing expectations by -44.95%.
Earnings released on 14 May 2024
EPS came in at -$0.11 falling short of the estimated -$0.09 by -22.22%, while revenue for the quarter reached $1.38m , beating expectations by +14.77%.
Earnings released on 13 Feb 2024
EPS came in at -$0.14 matching the estimated -$0.14, while revenue for the quarter reached $977.65k , beating expectations by +15.02%.
Earnings released on 14 Dec 2023
EPS came in at -$0.13 surpassing the estimated -$0.18 by +25.71%, while revenue for the quarter reached $742.00k , missing expectations by -7.25%.
Earnings released on 14 Aug 2023
EPS came in at -$0.20 surpassing the estimated -$0.21 by +2.44%, while revenue for the quarter reached $629.91k , beating expectations by +85.54%.
Earnings released on 11 May 2023
EPS came in at -$0.21 falling short of the estimated -$0.21 by -2.44%, while revenue for the quarter reached $466.18k , beating expectations by +105.82%.
Earnings released on 13 Feb 2023
EPS came in at -$0.11 surpassing the estimated -$0.16 by +29.03%, while revenue for the quarter reached $1.57m , beating expectations by +65.24%.
Earnings released on 22 Dec 2022
EPS came in at -$0.08 surpassing the estimated -$0.11 by +27.27%, while revenue for the quarter reached $2.01m , beating expectations by +11.72%.
Earnings released on 11 Aug 2022
EPS came in at -$0.17 surpassing the estimated -$0.23 by +24.44%, while revenue for the quarter reached $32.05k .
Earnings released on 12 May 2022
EPS came in at -$0.19 surpassing the estimated -$0.20 by +5.00%, while revenue for the quarter reached $36.58k , missing expectations by -4.76%.
Earnings released on 14 Feb 2022
EPS came in at -$0.18 surpassing the estimated -$0.19 by +2.70%, while revenue for the quarter reached $33.75k , missing expectations by -36.32%.
Earnings released on 15 Dec 2021
EPS came in at -$0.22 surpassing the estimated -$0.24 by +6.38%, while revenue for the quarter reached $48.34k , missing expectations by -3.33%.
Earnings released on 13 Aug 2021
EPS came in at -$0.25 , while revenue for the quarter reached $40.10k .
NMTC Stock Performance
Access detailed NMTC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
